Objective measurements, such as circadian phase and period assessments (e.g., fibroblast-derived circadian period) or light sensitivity tests (e.g., melatonin suppression test, melanopsin-mediated pupil response), could also provide more precise biomarkers for identifying hypersomnolence disorders in depression. Here, OPN4 is linked to depressive symptom measurement.